4.25 tirzepatide Day 4: Zepbound (Tirzepatide – weight loss indication) FDA Approved: November 2023 for weight management Weight Loss: Up to 22.5% in clinical trials Similar to Mounjaro, but marketed specifically for weight management Whey Variant:100mg LifeAfterGLP1 #GLP1Journey #MounjaroJourney #Tirzepatide

4.25 tirzepatide Day 4: Zepbound (Tirzepatide – weight loss indication) FDA Approved: November 2023 for weight management Weight Loss: Up to 22.5% in clinical trials Similar to Mounjaro, but marketed specifically for weight management Whey Variant:100mg LifeAfterGLP1 #GLP1Journey #MounjaroJourney #Tirzepatide

LifeAfterGLP1 #GLP1Journey #MounjaroJourney #Tirzepatide #WeightLossJourney 4 weeks off GLP-1… prediction time 👀 Will I regain the weight?

It is slightly more complex than using a single vial size throughout, but it optimizes both measurement precision and syringe convenience at every stage

Whey

Variant:100mg

The nine trends they identified are: Feeling “normal” in their bodies and in their relationship to food is a powerful emotional benefit for many users